4//SEC Filing
Leverone Jason A. 4
Accession 0001415889-25-002311
CIK 0001637715other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 8:35 PM ET
Size
5.6 KB
Accession
0001415889-25-002311
Insider Transaction Report
Form 4
Leverone Jason A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-27+65,000→ 65,000 totalExercise: $5.19Exp: 2035-01-26→ Class A Common Stock (65,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option shall vest on February 27, 2025 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
OnKure Therapeutics, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001692747
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 8:35 PM ET
- Size
- 5.6 KB